Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Kymera Therapeutics (KYMR) Institutional Ownership

Kymera Therapeutics logo
$78.14 -1.53 (-1.92%)
Closing price 04:00 PM Eastern
Extended Trading
$78.16 +0.02 (+0.02%)
As of 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Kymera Therapeutics (NASDAQ:KYMR)

Number of
Institutional Buyers
(last 12 months)
163
Total
Institutional Inflows
(last 12 months)
$1.06B
Number of
Institutional Sellers
(last 12 months)
79
Total
Institutional Outflows
(last 12 months)
$512.71M
Get KYMR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kymera Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

KYMR Institutional Buying and Selling by Quarter

Kymera Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026 Bank of America Corp DE289,416$24.11M0.0%-14.6%0.352%
5/18/2026 Amundi2,988$249K0.0%N/A0.004%
5/18/2026 California State Teachers Retirement System56,282$4.69M0.0%+23.0%0.068%
5/18/2026 Royal Bank of Canada730$60K0.0%-67.7%0.001%
5/18/2026 Eagle Health Investments LP145,816$12.15M2.1%+7.0%0.177%
5/18/2026 Empowered Funds LLC2,438$203K0.0%N/A0.003%
5/16/2026 The Manufacturers Life Insurance Company 120,151$10.01M0.0%-11.6%0.146%
5/15/2026 Octagon Capital Advisors LP425,000$35.40M3.9%-20.6%0.517%
5/14/2026 Atlas Venture Life Science Advisors LLC4,578,008$381.30M48.3%-1.8%5.565%
5/14/2026 Siren L.L.C.3,186,830$265.43M7.4%-3.0%3.874%
5/14/2026 Inceptionr LLC3,618$301K0.1%N/A0.004%
5/14/2026 Sei Investments Co.11,225$935K0.0%-15.3%0.014%
5/14/2026 Monashee Investment Management LLC35,100$2.92M1.6%-64.9%0.043%
5/13/2026 Cetera Investment Advisers3,602$300K0.0%+7.5%0.004%
5/13/2026 First Trust Advisors LP93,617$7.80M0.0%+59.0%0.114%
5/8/2026 PNC Financial Services Group Inc.1,285$107K0.0%+56.3%0.002%
5/7/2026 WCM Investment Management LLC152,381$12.11M0.0%+44.9%0.185%
5/7/2026 Dimensional Fund Advisors LP592,879$49.36M0.0%-5.0%0.721%
5/7/2026 AlphaCentric Advisors LLC5,342$445K0.4%+6.1%0.006%
5/7/2026 Swiss National Bank94,500$7.87M0.0%+0.3%0.115%
5/6/2026 Jennison Associates LLC508,999$42.40M0.0%+2.5%0.619%
5/5/2026 Marks Group Wealth Management Inc4,003$333K0.0%N/A0.005%
5/5/2026 Bank of New York Mellon Corp193,200$16.09M0.0%+0.2%0.235%
5/4/2026 Principal Financial Group Inc.4,147$345K0.0%+24.4%0.005%
5/1/2026 Fifth Third Bancorp51,238$4.27M0.0%N/A0.063%
4/28/2026 Abel Hall LLC4,833$403K0.1%-17.2%0.006%
4/22/2026 Pictet Asset Management Holding SA468,728$38.76M0.0%-3.0%0.574%
4/20/2026 Keudell Morrison Wealth Management6,990$582K0.1%+5.9%0.009%
4/16/2026 SG Americas Securities LLC3,163$263K0.0%-86.1%0.004%
3/20/2026 Hsbc Holdings PLC7,619$597K0.0%-26.1%0.009%
3/17/2026 Rockefeller Capital Management L.P.25,533$1.99M0.0%+21,538.1%0.031%
3/3/2026 Caitong International Asset Management Co. Ltd2,542$198K0.0%N/A0.003%
2/23/2026 Virtu Financial LLC27,283$2.12M0.1%N/A0.038%
2/19/2026 T. Rowe Price Investment Management Inc.629,745$49.00M0.0%+3.0%0.875%
2/19/2026 Invesco Ltd.116,747$9.08M0.0%+46.3%0.162%
2/18/2026 Vident Advisory LLC7,581$590K0.0%+6.5%0.011%
2/18/2026 Mackenzie Financial Corp3,464$270K0.0%N/A0.005%
2/18/2026 XTX Topco Ltd24,143$1.88M0.0%N/A0.034%
2/18/2026 Yiheng Capital Management L.P.73,440$5.71M1.2%-40.1%0.102%
2/18/2026 Virtus Investment Advisers LLC2,966$231K0.1%+23.3%0.004%
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
2/18/2026 Wellington Management Group LLP4,412,933$343.37M0.1%-15.1%6.133%
2/18/2026 RTW Investments LP240,000$18.67M0.2%N/A0.334%
2/18/2026 Odyssean LLC9,347$727K0.5%N/A0.013%
2/18/2026 Perceptive Advisors LLC69,935$5.44M0.1%-58.8%0.097%
2/18/2026 Millennium Management LLC11,243$875K0.0%-88.2%0.016%
2/18/2026 Man Group plc20,026$1.56M0.0%N/A0.028%
2/18/2026 Janus Henderson Group PLC21,058$1.64M0.0%+15.0%0.029%
2/18/2026 Clough Capital Partners L P10,925$850K0.1%N/A0.015%
2/18/2026 Baker BROS. Advisors LP8,657,242$673.62M3.9%+30.2%12.032%
2/18/2026 Bamco Inc. NY20,000$1.56M0.0%+185.7%0.028%
2/18/2026 Armistice Capital LLC81,165$6.32M0.1%N/A0.113%
2/17/2026 Guggenheim Capital LLC10,307$802K0.0%N/A0.014%
2/17/2026 Logos Global Management LP130,000$10.12M0.6%-48.0%0.181%
2/17/2026 AQR Capital Management LLC9,339$727K0.0%+8.3%0.013%
2/17/2026 Braidwell LP454,259$35.35M1.1%+64.2%0.631%
2/17/2026 Cetera Investment Advisers3,350$261K0.0%N/A0.005%
2/17/2026 Abel Hall LLC5,836$454K0.1%N/A0.008%
2/17/2026 Trexquant Investment LP24,680$1.92M0.0%-66.2%0.034%
2/17/2026 Price T Rowe Associates Inc. MD6,159,335$479.26M0.1%+20.8%8.561%
2/17/2026 T. Rowe Price Investment Management Inc.96,833$7.54M0.0%-84.2%0.135%
2/17/2026 Rock Springs Capital Management LP496,871$38.66M2.0%+10.3%0.691%
2/17/2026 Adage Capital Partners GP L.L.C.430,000$33.46M0.1%+80.7%0.598%
2/17/2026 California State Teachers Retirement System45,742$3.56M0.0%+12.4%0.064%
2/17/2026 Russell Investments Group Ltd.45,977$3.58M0.0%+142.1%0.064%
2/17/2026 State of Wisconsin Investment Board26,513$2.06M0.0%-4.5%0.037%
2/17/2026 Fred Alger Management LLC18,639$1.45M0.0%N/A0.026%
2/17/2026 Avoro Capital Advisors LLC7,474,747$581.61M5.6%+17.7%9.156%
2/17/2026 Royal Bank of Canada2,263$176K0.0%-99.0%0.003%
2/17/2026 Polar Capital Holdings Plc200,946$15.64M0.1%-49.4%0.279%
2/16/2026 Squarepoint Ops LLC159,426$12.41M0.0%-54.6%0.222%
2/16/2026 Verition Fund Management LLC54,319$4.23M0.0%+72.6%0.075%
2/16/2026 Mosaic Financial Group LLC2,890$225K0.2%N/A0.004%
2/16/2026 Maven Securities LTD15,000$1.17M0.0%N/A0.021%
2/16/2026 Nicholas Investment Partners LP55,788$4.34M0.3%+6.0%0.078%
2/16/2026 First Turn Management LLC206,445$16.06M1.8%-25.7%0.287%
2/16/2026 Kennedy Capital Management LLC12,523$974K0.0%+32.1%0.017%
2/16/2026 Eventide Asset Management LLC626,430$48.74M0.8%-2.8%0.871%
2/16/2026 Barclays PLC140,507$10.93M0.0%-9.4%0.195%
2/16/2026 Aigen Investment Management LP9,098$708K0.2%-23.4%0.013%
2/13/2026 Marshall Wace LLP38,022$2.96M0.0%-89.4%0.053%
2/13/2026 The Manufacturers Life Insurance Company 135,894$10.61M0.0%+7.4%0.189%
2/13/2026 CANADA LIFE ASSURANCE Co3,931$306K0.0%-62.5%0.005%
2/13/2026 Walleye Capital LLC19,181$1.49M0.0%N/A0.027%
2/13/2026 Smartleaf Asset Management LLC535$42K0.0%+382.0%0.001%
2/13/2026 Schroder Investment Management Group52,671$4.12M0.0%-14.6%0.073%
2/13/2026 Rafferty Asset Management LLC58,653$4.56M0.0%-14.1%0.082%
2/13/2026 First Trust Advisors LP58,862$4.58M0.0%-21.4%0.082%
2/13/2026 Alyeska Investment Group L.P.371,889$28.94M0.1%-39.5%0.517%
2/13/2026 Siren L.L.C.3,286,830$255.75M7.6%-4.1%4.568%
2/13/2026 Charles Schwab Investment Management Inc.497,026$38.67M0.0%+13.0%0.691%
Your book is inside (Ad)

The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel

Download your copy now.
2/13/2026 Police & Firemen s Retirement System of New Jersey15,030$1.17M0.0%+7.8%0.021%
2/13/2026 State Street Corp2,209,837$171.95M0.0%+9.4%3.071%
2/13/2026 Caitong International Asset Management Co. Ltd807$63K0.2%N/A0.001%
2/13/2026 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC912,498$71.00M0.0%+5.6%1.268%
2/13/2026 Wells Fargo & Company MN66,489$5.17M0.0%+107.4%0.092%
2/13/2026 Atlas Venture Life Science Advisors LLC4,659,874$362.59M41.9%-4.8%6.477%
2/12/2026 HRT Financial LP18,173$1.41M0.0%N/A0.025%
2/12/2026 Orion Porfolio Solutions LLC2,868$223K0.0%N/A0.004%
2/12/2026 MetLife Investment Management LLC31,394$2.44M0.0%+6.4%0.044%
2/12/2026Cibc World Markets Corp3,732$290K0.0%N/A0.005%


KYMR Institutional Ownership - Frequently Asked Questions

During the previous two years, 242 institutional investors and hedge funds held shares of Kymera Therapeutics. The most heavily invested institutionals were Baker BROS. Advisors LP ($673.62M), Avoro Capital Advisors LLC ($581.61M), Vanguard Group Inc. ($487.69M), Price T Rowe Associates Inc. MD ($479.26M), Atlas Venture Life Science Advisors LLC ($381.30M), Wellington Management Group LLP ($343.37M), and Siren L.L.C. ($265.43M).Learn more on Kymera Therapeutics' institutional investors.

Of the 212 institutional investors that purchased Kymera Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Baker BROS. Advisors LP ($2.01M), Avoro Capital Advisors LLC ($1.77M), Wellington Management Group LLP ($1.69M), Vanguard Group Inc. ($1.32M), Price T Rowe Associates Inc. MD ($1.29M), Holocene Advisors LP ($840.33K), and Federated Hermes Inc. ($763.92K).

Institutional investors have bought a total of 16,273,539 shares in the last 24 months. This purchase volume represents approximately $1.06B in transactions.

Of the 79 institutional investors that sold Kymera Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Wellington Management Group LLP ($959.13K), Jennison Associates LLC ($531.07K), T. Rowe Price Investment Management Inc. ($514.39K), AJU IB Investment Co. Ltd. ($437.41K), Marshall Wace LLP ($321.05K), Atlas Venture Life Science Advisors LLC ($318.45K), and Woodline Partners LP ($250.11K).

Institutional investors have sold a total of 7,213,787 shares in the last 24 months. This volume of shares sold represents approximately $512.71M in transactions.


Related Companies

This page (NASDAQ:KYMR) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel